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The Nef proteins of Simian immunodeficiency virus (SIV) and human immunodeficiency virus (HIV) have been shown to
associate with several cellular kinases. Further, the ability of SIVmac239 Nef to associate with a p21-activated kinase
(PAK)-related kinase has been correlated with pathogenic progression to AIDS in rhesus macaques. Because the ability of
Nef to associate with the PAK-related kinase is viral isolate dependent, we reasoned that viral isolates derived from distinct
physiological locations may encode Nef proteins that exhibit distinct kinase association profiles. In this study, we compared
kinase activities associated with Nef proteins derived from the prototypic lymphocyte-tropic SIVmac239 and a macrophage-
tropic, neurovirulent clone, SIV/17E-Fr. Our findings not only support previous studies that have documented the association
of SIVmac239 Nef with a PAK-related kinase and a Nef-associated kinase complex (NAKC) but describe a novel serine kinase
activity detectable only in conjunction with the Nef protein derived from the neurovirulent clone, SIV/17E-Fr. The latter Nef
protein does not associate with PAK, and unlike PAK or NAKC, this novel kinase activity is enhanced in association with
nonmyristoylated forms of Nef and can utilize both ATP and GTP as phosphodonors. We also show that at least one substrate
for the kinase is Nef itself and demonstrate that the SIV/17E-Fr Nef protein is phosphorylated in SIV-infected cells. These
results suggest that the ability to associate with cellular kinases in general may be a conserved feature of Nef, but particular
kinase/Nef associations may evolve with changes in the host environment concomitant with viral spread. © 1998 Academic Press
INTRODUCTION
Encephalitits and dementia are among the common
pathological complications associated with human im-
munodeficiency virus (HIV) infection (Power et al., 1993;
Price et al., 1988). Virus isolated from the central nervous
system (CNS) of AIDS dementia patients is ostensibly
macrophage tropic; however, not all individuals infected
with macrophage-tropic strains of HIV develop neurolog-
ical disease (Cheng-Mayer et al., 1989; Price et al., 1988,
1990). Thus all macrophage-tropic viruses are not simul-
taneously neurovirulent, suggesting other viral factors
(distinct from tropism determinants) contribute to the
development of dementia. The Simian immunodeficiency
virus (SIV) macaque model provides a powerful research
system to study AIDS dementia because SIV-induced
CNS disease mirrors key clinical and pathological fea-
tures of HIV-induced encephalitis (Letvin and King, 1990;
Ringler et al., 1998).
Previously, we described the derivation of the mac-
rophage-tropic, neurovirulent virus SIV/17E-Br from mul-
tiple in vivo passages of the prototypic lymphocyte-tropic
virus SIVmac239 (Sharma et al., 1992). To identify the
molecular determinants that contributed to the evolution
of SIV/17E-Br, a panel of infectious molecular clones was
subsequently prepared and characterized. SIV/17E-Cl, a
clone containing a portion of SIV/17E-Br env in the ge-
netic background of SIVmac239, was able to replicate in
macrophages but failed to induce neurological pathology
in macaques (Anderson et al., 1993; Flaherty et al., 1997;
Mankowski et al., 1997). SIV/17E-Fr, a clone containing
the env, nef, and 39 LTR of SIV/17E-Br in the genetic
background of SIVmac239, replicated to higher titers in
macrophages than SIV/17E-Cl and caused encephalitis
in macaques (Flaherty et al., 1997; Mankowski et al.,
1997). Further, four of four macaques that developed
severe neurological disease after dual infection with
SIV/17E-Fr and SIV/DeltaB670 (a swarm of both mac-
rophage-tropic and lymphocyte-tropic viruses) had de-
tectable SIV/17E-Fr DNA in the brain, and in three of
these four macaques, SIV/17E-Fr DNA was the only de-
tectable SIV genotype in the brain (Zink et al., 1997).
Collectively, these studies suggest that although env
sequences of macrophage-tropic, neurovirulent SIV/
17E-Br are sufficient to confer macrophage tropism on
lymphocyte-tropic SIVmac239, the additional presence of
a full-length nef gene (not present in SIV/17E-Cl) is re-
quired for optimal viral replication in vitro and may con-
tribute to the development of CNS disease in vivo.
The nef genes of HIV and SIV encode a nonstructural
1 To whom reprint requests should be addressed at 720 Rutland
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VIROLOGY 251, 165–175 (1998)
ARTICLE NO. VY989408
0042-6822/98 $25.00
Copyright © 1998 by Academic Press
All rights of reproduction in any form reserved.
165
protein that is functionally interchangeable between
these two lentiviruses (Sinclair et al., 1997). Previous
studies have determined that the nef gene is required for
viral replication and pathogenesis in vivo (Daniel et al.,
1992; Jamieson et al., 1994; Kestler et al., 1991) and that
Nef contributes to the down-regulation of MHC I and
CD4 (the primary receptor for HIV and SIV) from the
surface of infected cells (Guy et al., 1987; Schwartz et al.,
1996), enhanced virion infectivity (Chowers et al., 1994),
and optimal replication in vitro (Flaherty et al., 1997).
Most recently, it has been suggested that Nef also plays
a role in the induction of c-kit in HIV- and SIV-infected
astrocytes, perhaps promoting apoptosis in these cells
(He et al., 1997). Despite such demonstrations of func-
tional versatility, the mechanisms by which Nef mediates
these and other potential functions are not well defined.
Nef is expressed in two forms in the infected cell: a
membrane-associated, myristoylated form and a non-
myristoylated form (Guy et al., 1987). The myristoylated
form is required for virion incorporation of Nef, as well as
Nef-mediated enhancement of viral infectivity and down-
regulation of CD4 (Flaherty et al., 1997 ; Harris and Neil,
1994 ; Pandori et al., 1996 ). Nef also contains multiple
potential phosphorylation sites (Guy et al., 1987), is itself
regulated by phosphorylation (Bandres et al., 1994; Luo
et al., 1997) and can be phosphorylated in vitro by protein
kinase C (PKC) and lck (Bodeus et al., 1995; Coates et al.,
1997; Coates and Harries, 1995; Collette et al., 1995; Guy
et al., 1987, 1990; Luo et al., 1997). Moreover, Nef has
been shown to alter signaling pathways (De and Marsh,
1994; Graziani et al., 1996; Greenway et al., 1995; Iafrate
et al., 1997; Luria et al., 1991; Niederman et al., 1992;
Richard et al., 1996; Romero et al., 1998) and modulate
the activities of a number of cellular kinases, including
lck (Collette et al., 1995; Greenway et al., 1996), hck
(Briggs et al., 1997; Moarefi et al., 1997), mitogen-acti-
vated protein kinase (MAPK) (Greenway et al., 1996),
PKC-u (Smith et al., 1996), a p21-activated kinase (PAK)-
related kinase (Nunn and Marsh, 1996; Sawai et al.,
1994), and an unidentified serine kinase present in the
Nef-associated kinase complex (NAKC; Baur et al., 1997).
Association with the NAKC and possibly the PAK-related
kinase correlates with Nef-mediated enhancement of
viral infectivity (Baur et al., 1997; Luo and Garcia, 1996).
Further, mutations of R137 and R138 in SIVmac239 nef,
which inhibit the association of Nef with the PAK-related
kinase, revert after inoculation of SIVmac239 into rhesus
macaques (Sawai et al., 1996), suggesting the impor-
tance of this kinase association for disease progression
in vivo, at least with respect to virus isolated from the
peripheral blood of infected animals.
We have long been interested in studying the mecha-
nisms or processes leading to the development of SIV-
induced CNS disease. In doing so, we described the
isolation of a neurovirulent macrophage-tropic clone,
SIV/17E-Fr, and reported that the Nef protein of this clone
differs in sequence from the parental lymphocyte-tropic
clone SIVmac239 Nef (Flaherty et al., 1997). In light of
recent publications describing Nef-associated kinase
activities and the fact that the expression of certain
kinases and hence, certain signaling pathways, is cell
type specific (Hardie and Hanks, 1995), we considered
the possibility that Nef proteins derived from neuroviru-
lent viruses and classically lymphocyte-tropic viruses
may selectively associate with different cellular kinases,
with the idea that kinase associations may evolve during
in vivo passage, but those important for viral growth in
certain tissues (i.e., the CNS or periphery) may be con-
served. In this report, we characterize a novel serine
kinase activity associated with SIV/17E-Fr Nef that phos-
phorylates Nef and is distinct from both the PAK-related
kinase and NAKC. We also demonstrate that SIV/17E-Fr
Nef is phosphorylated in SIV-infected cells.
RESULTS
SIV/17E-Fr and SIVmac239 Nef proteins exhibit
distinct in vitro kinase assay profiles in SIV-infected
primary rhesus macaque macrophages
To compare the kinase activities associated with dis-
tinct Nef proteins, we performed in vitro kinase assays
on Nef derived from SIV/17E-Fr and another clone, SIV/
Fr-2. SIV/Fr-2 is identical to SIV/17E-Fr except that the
SIV/17E-Fr nef has been replaced with SIVmac239 nef
open, resulting in five amino acid coding differences
(Flaherty et al., 1997). Like SIV/17E-Fr, SIV/Fr-2 is macro-
phage tropic and thus grows well in primary rhesus
macaque macrophages. Nef immunoprecipitates (Nef
IPs), prepared from macrophages infected with SIV/
17E-Fr or SIV/Fr-2 for 5 days, were compared in in vitro
kinase assays. SIVmac239 Nef (present in SIV/Fr-2) as-
sociated with phosphoprotein (pp)62 and pp97 (Fig. 1A,
top arrowheads), as shown in previous reports (Nunn
and Marsh, 1996; Sawai et al., 1994) that subsequently
identified pp62 as a PAK-related kinase. A third phospho-
protein, pp35, also associated with the SIV/Fr-2 Nef but
invariably to a lesser extent (light band, Fig. 1A, lowest
arrowhead). This kinase activity likely represents a
serine kinase activity of NAKC, recently shown to phos-
phorylate SIVmac239 Nef (MW ;35 kDa) in a complex
with PAK (Baur et al., 1997). In contrast to SIV/Fr-2 Nef,
SIV/17E-Fr Nef associated only with pp35 and not with
pp62 or pp97. To ensure that the observed differences in
Nef-associated kinase activities did not simply reflect
differences in levels of Nef due to variability in viral
replication or sequence-specific differences in IP effi-
ciency, we transfected CEM3174 cells with infectious
SIV/17E-Fr or SIV/Fr-2 DNA and prepared whole-cell ly-
sates when both cultures had reached high RT levels
and thus were most likely to express the same amounts
of Nef protein. Western blot analysis (Fig. 1B, bottom)
confirmed that comparable amounts of Nef were present
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in Nef IPs prepared from the same lysates where parallel
Nef IPs exhibited distinct in vitro kinase assay patterns
(Fig. 1B, top).
Myristoylation mutants of SIV/17E-Fr Nef exhibit
increased association with pp35
Both SIV and HIV Nef proteins exist in two forms: a
membrane-associated, myristoylated form and a non-
myristoylated (2myr) form (Guy et al., 1987). To deter-
mine whether the association of SIV/17E-Fr Nef with
pp35 is dependent on the myristoylation of Nef, infec-
tious clones were prepared that contained mutations of
the amino-terminal glycine residue required for Nef my-
ristoylation (Bhatnagar and Gordon, 1997). In vitro kinase
assays were performed with Nef IPs prepared (at high RT
levels) from U937 cells transfected with the infectious
DNA of SIV/Fr-2, SIV/17E-Fr, myristoylation mutants SIV/
17E-Fr (2myr) and SIV/Fr-2 (2myr), and SIV/Dnef, a clone
containing a 182-bp deletion plus a mutation at the initi-
ating methionine of SIV/17E-Fr nef (Flaherty et al., 1997).
Consistent with a previous report (Sawai et al., 1995), the
ability of SIVmac239 Nef, present in clone Fr-2, to asso-
ciate with pp62 was largely dependent on Nef-myristoyl-
ation (Fig. 2), as decreased levels of pp62 were detected
in cells transfected with DNA from SIV/Fr-2 (2myr). The
ability of SIV/Fr-2 Nef to associate with pp97 and pp35
was also dependent on myristoylated Nef but possibly to
a lesser extent for pp35 because this band was consis-
tently lighter than pp62 and pp97 in assays of SIV/Fr-2
Nef and thus potentially just below the level of detection
in assays of SIV/Fr-2 (2myr) Nef. In marked contrast,
increased levels of pp35 associated with SIV/17E-Fr
(2myr) Nef, demonstrating for the first time that a non-
myristoylated form of Nef favors a particular kinase as-
sociation in infected cells. Comparable levels of Nef
were immunoprecipitated from [35S]methionine-labeled
lysates prepared in parallel from the same cultures of the
myristoylation mutants (not shown). We consistently ob-
served this disparate effect of Nef myristoylation on pp35
levels in in vitro kinase assays prepared from SIV-in-
fected U937 cells, primary rhesus macaque macro-
phages, and CEM3174 cells (not shown), which sug-
gested that the SIV/17E-Fr Nef/pp35 kinase and SIV/Fr-2
Nef/pp35 kinase (of NAKC) may be different. The speci-
ficity of the kinase assays for Nef was confirmed by the
lack of specific phosphoproteins in kinase assays of
SIV/Dnef IPs; all bands except pp97, pp65, and pp35
appeared in SIV/Dnef IPs after longer film exposure (not
shown).
SIV/17E-Fr Nef-associated kinase can utilize GTP and
is inhibited by staurosporine
Although ATP is the preferred phosphodonor for most
kinases, some kinases can utilize both ATP and GTP. To
determine whether the p35-kinase(s), associating with
FIG. 2. In vitro kinase assays of Nef immunoprecipitates prepared
from U937 cells transfected with DNA from each of the indicated SIV
recombinant clones, as described in Materials and Methods. Nef
myristoylation mutants are designated (2myr). The RT levels (cpm/ml)
at the time of lysis were: 17E-Fr, 190380; 17E-Fr (2myr), 75798; Fr-2,
153280; Fr-2 (2myr), 96051; Dnef, 85535. The results are representative
of at least three independent experiments performed on Nef immuno-
precipitates from transfected CEM3174 cells or U937 cells. The com-
puter-generated image of the scanned autoradiograph was produced
using Adobe Photoshop 4.0 and Adobe Illustrator 6.0.
FIG. 1. (A) In vitro kinase assay of Nef immunoprecipitates prepared
from primary rhesus macaque macrophages infected for 5 days with
SIV/17E-Fr or SIV/Fr-2, as described in Materials and Methods. RT
levels (cpm/ml) at the time of cells lysis were 16953 (SIV/17E-Fr) and
8276 (SIV/Fr-2). (B, Top) In vitro kinase assay of Nef immunoprecipitates
prepared from CEM3174 cells transfected with SIV/17E-Fr or SIV/Fr-2
DNA, as described in Materials and Methods. RT levels (in cpm/ml) at
the time of cells lysis were 219247 (SIV/17E-Fr) and 254144 (SIV/Fr-2).
(Bottom) Western blot analysis of Nef immunoprecipitates prepared in
parallel from the same lysates used in the in vitro kinase assays shown
in the top. Results are representative of at least three independent
experiments performed on Nef immunoprecipitates prepared from SIV-
infected rhesus macaque macrophages and transfected CEM3174 or
U937 cells. The computer-generated images were produced using
Adobe Photoshop 4.0 and Adobe Illustrator 6.0.
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the SIV/17E-Fr and SIV/Fr-2 Nef proteins, could utilize
GTP and ATP, we compared in vitro kinase assays in the
presence of [g-32P]ATP or [g-32P]GTP (Fig. 3A). Although
pp35 was readily detectable in ATP-based assays of both
Nef proteins, pp35 was only detectable in GTP-based
assays of the SIV/17E-Fr Nef protein and not the SIV/Fr-2
Nef protein, confirming our suspicions that the SIV/
17E-Fr and SIV/Fr-2 Nef-associated pp35 kinases were
distinct. Even after prolonged exposure, pp35 was never
observed in association with SIV/Fr-2 Nef in the GTP-
based assays. To further characterize the SIV/17E-Fr
Nef-associated kinase activity, in vitro kinase assays
were performed in the presence of the serine/threonine
kinase inhibitor staurosporine, the tyrosine kinase inhib-
itor genistein, and the vehicle control DMSO. The kinase
activity associated with SIV/17E-Fr Nef was inhibited
only by staurosporine, as indicated by the loss of pp35
(Fig. 3B), suggesting that this kinase is a serine/threo-
nine kinase. SIV/Fr-2-associated pp35 was also inhibited
by staurosporine, whereas the intensities of nonspecific
bands were essentially unaffected by the presence of
staurosporine (not shown).
Inhibition by staurosporine is a strong indicator that
the novel kinase associated with SIV/17E-Fr Nef is a
serine/threonine kinase. To identify the amino acid(s)
phosphorylated by the SIV/17E-Fr Nef-associated kinase,
phosphoamino acid analysis was performed on pp35
excised from a rehydrated in vitro kinase gel. We ana-
lyzed pp35 associated with SIV/17E-Fr Nef immunopre-
cipitated from primary rhesus macaque macrophages
infected with SIV/17E-Fr and from CEM3174 and U937
cells transfected with infectious SIV/17E-Fr DNA. The
results were identical in all cases; pp35 was phosphor-
ylated exclusively on serine(s) (Fig. 3C).
SIV/17E-Fr Nef-associated kinase phoshorylates Nef
Because SIV/17E-Fr-associated pp35 comigrates with
[35S]methionine-labeled Nef in SDS–PAGE (not shown)
and with the pp35 kinase assay product associated with
SIVmac239 Nef (present in SIV/Fr-2; Figs. 1 and 2), which
likely represents NAKC-phosphorylated Nef (Baur et al.,
1997), we examined the possibility that the SIV/17E-Fr-
associated pp35 also represents phosphorylated Nef. To
this end, we utilized a combination of two-dimensional
protein separation techniques and Western blot analysis.
First, Nef IPs prepared from [35S]methionine-labeled
CEM3174 cells transfected with the DNA of SIV/Fr-2 or
SIV/17E-Fr (2myr) were separated in one dimension
using standard SDS–PAGE (Fig. 4A). The only Nef-spe-
cific protein band (not present in the Mock-transfected
cells), of ;35 kDa was excised from the polyacrylamide
gel and separated in the second dimension by isoelec-
tric focusing (Fig. 4C). The [35S]-label from both SIV/Fr-2
and SIV/17E-Fr p35 bands concentrated essentially into
single spots (see Materials and Methods) that migrated
to pIs between 5.1 and 6.0. The different pIs likely reflect
the amino acid differences between the two Nef proteins
and are consistent with the pIs of both SIV/Fr-2 Nef (5.35)
and SIV/17E-Fr Nef (6) as predicted by the computer
analysis program, MacVector, in the absence of post-
translational modifications. These data indicate that the
predominant [35S]methionine-labeled 35-kDa protein
present in Nef IPs is Nef itself. Supporting this conclu-
sion is our observation that [32P]-labeled SIV/17E-Fr Nef
(cleaved and purified from a GST–Nef fusion protein)
migrates to the same region in IEF gels (not shown). We
next performed two-dimensional analysis of pp35 de-
rived from in vitro kinase assays of Nef IPs prepared from
FIG. 3. In vitro kinase assays of Nef immunoprecipitates prepared
from CEM3174 cells transfected with SIV/17E-Fr or SIV/Fr-2 DNA, as
described in Materials and Methods, in the presence of (A) 200 mM
[g-32P] ATP (3000 Ci/mol) or 200 mM [g-32P] GTP (6000 Ci/mol) or (B) 10
mM staurosporine (STAUR.), 100 mM genistein (GEN.), or DMSO, used
at the highest concentration present in either inhibitor (1%). RTs (cpm/
ml) at the time of lysis were 108167 for SIV/17E-Fr and 112866 for
SIV/Fr-2 (A) and 80754 for SIV/17E-Fr and 80383 for SIV/Fr-2 (B). Results
are representative of at least three similar independent experiments.
(C) Phosphoamino acid analysis of pp35 extracted from in vitro kinase
gels of Nef immunoprecipitates prepared from CEM3174 cells trans-
fected with SIV/17E-Fr DNA, as described in Materials and Methods.
The circles corresponding to Ser (serine), Thr (threonine), and Tyr
(tyrosine) represent the positions of the phosphoamino acid standards.
Results are representative of three independent analyses of pp35
derived from Nef in vitro kinase assays of infected primary rhesus
macaque macrophages and transfected CEM3174 or U937 cells. The
computer-generated images of the scanned autoradiographs were
produced using Adobe Photoshop 4.0 and Adobe Illustrator 6.0.
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parallel but unlabeled cultures of transfected CEM3174
cells. Separation of pp35 in the first dimension showed
the typical difference in pp35 intensity seen when com-
paring SIV/Fr-2 and SIV/17E-Fr (2myr) Nef kinase assays
(Fig. 4B). Separation of pp35 in the second dimension
(Fig. 4D) again resulted in the concentration of the radio-
active label, [32P], into spots that migrated to the same
relative positions in the IEF gels (i.e., between 5.1 and
6.0) and whose difference in [32P] intensity reflected the
difference observed in pp35 after separation in the first
dimension (Fig. 4B). These results strongly suggested
that pp35 was phosphorylated Nef. To confirm this result
using a more direct approach, the proteins in the IEF gel
were transferred to Immobilon and subjected to Western
blot analysis (using Nef antiserum) as described in Ma-
terials and Methods. After ECL detection, in which the
blots were exposed to film for 1–3 s (Fig. 4E), two spots
of equal intensity appeared that were superimposable
over the spots observed in the IEF gel (Fig. 4D). This
result is consistent with our findings that equal levels of
Nef are present in transfected CEM3174 cells at peak
virus production and demonstrates unequivocally that
pp35 is phosphorylated Nef.
SIV/17E-Fr Nef is phosphorylated in SIV-infected cells
Thus far, our studies have revealed a novel serine
kinase activity present in IPs of SIV/17E-Fr Nef that both
phosphorylates Nef and is distinct from the two previ-
ously described serine kinase activities associated with
SIVmac239 Nef in in vitro kinase assays. As the first step
in assessing the potential relevance of this in vitro ob-
servation to events occurring during viral replication, we
examined the phosphorylation state of Nef in infected
CEM3174 cells. Nef IPs prepared from 32P-orthophos-
phate-labeled CEM3174 cells transfected with the DNA
of SIV/Fr-2 or SIV/17E-Fr were separated using standard
SDS–PAGE and analyzed by autoradiography (Fig. 5).
The ;35-kDa phosphoprotein was detected only in Nef
IPs from SIV/17E-Fr lysates, supporting the possibility
that our in vitro observations may reflect the activity(ies)
of Nef in SIV-infected cells. There were no other specific
phosphoproteins detected after prolonged exposure,
whereas in vitro kinase assays of SIV/17E-Fr and SIV/
Fr-2, Nef IPs prepared from parallel unlabeled lysates
exhibited the same characteristic phosphoprotein pat-
terns described above in Figs. 1 and 2 (not shown).
These results indicate that the major in vitro kinase
products associated with SIVmac239 Nef, namely, pp62,
pp97, and pp35, may not represent Nef-associated phos-
phoproteins during SIV infection, that their level of phos-
phorylation during infection may be below the level of
detection, or that in vivo kinase substrates may differ
from those in in vitro kinase assays.
FIG. 4. (A) SDS–PAGE separation of Nef immunoprecipitates pre-
pared from [35S]methionine-labeled CEM3174 cells transfected with
SIV/17E-Fr (2myr) DNA or SIV/Fr-2 DNA, as described in Materials and
Methods. (B) In vitro kinase assays of Nef immunoprecipitates pre-
pared from parallel, but unlabeledm cultures of CEM’174 cells trans-
fected with SIV/Fr-2 DNA or SIV/17E-Fr (2myr) DNA, as described in
Materials and Methods. (C) Isoelectric focusing of p35 band excised
from the gel shown above in A. (D) Isoelectric focusing of pp35 excised
from the gel shown above in B. (E) Western blot analysis of the gel
shown in D. Results are representative of three independent two-
dimensional analyses of pp35. The computer-generated images of the
scanned autoradiographs were produced using Adobe Photoshop 4.0
and Adobe Illustrator 6.0.
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DISCUSSION
Although nef is required for viral replication and patho-
genesis in vivo (Daniel et al., 1992; Jamieson et al., 1994;
Kestler et al., 1991), the various mechanisms of Nef
functions during SIV or HIV in vivo infections are not
known and still under investigation. Nevertheless, many
versatile functions of Nef have been described. For ex-
ample, Nef plays a role in the down-regulation of CD4
and MHC I molecules, in part through accelerated endo-
cytosis and the promotion of clathrin-coated pit formation
(Aiken et al., 1994; Foti et al., 1997; Le Gall et al., 1998;
Rhee and Marsh, 1994; Schwartz et al., 1995, 1996). It is
thought that down-regulation of CD4, the primary recep-
tor for SIV and HIV, may serve to modulate CD4/TCR-
mediated signaling and discourage viral superinfection
(Aiken et al., 1994; Benson et al., 1993; Rhee and Marsh,
1994). Dependent on the viral entry pathway, Nef also
enhances virion infectivity (Aiken, 1997; Luo et al., 1998),
which correlates with its ability to stimulate proviral DNA
synthesis (Aiken and Trono, 1995; Chowers et al., 1995)
and to associate with NAKC and possibly with a PAK-
related kinase (Baur et al., 1997; Chowers et al., 1994;
Flaherty, Barber, and Clements, 1997; Luo and Garcia,
1996; Miller et al., 1994). Nef association with the acti-
vated PAK-related kinase is viral-isolate dependent, as
shown here and by Luo and Garcia (1996). In the present
study, we compared in vitro kinase assays of Nef IPs
prepared from rhesus macaque macrophages infected
with the neurovirulent clone SIV/17E-Fr or SIV/Fr-2, a
clone molecularly identical to SIV/17E-Fr except that it
contains SIVmac239 nef open (Flaherty et al., 1997). Our
results indicate that SIV17E-Fr Nef associates with a
novel kinase activity that results in the phosphorylation
of Nef itself. Nef phosphorylation can be achieved in the
presence of ATP or GTP (Fig. 3A), is inhibited by stauro-
sporine (Fig. 3B), and occurs exclusively on serine(s)
(Fig. 3C). We also found SIV/17E-Fr Nef to be phosphor-
ylated in SIV-infected cells and are currently mapping the
relevant phosphorylation sites in Nef derived from 32P-
labeled SIV-infected cells and in vitro kinase assays. Of
particular interest was the enhanced kinase association
or activation by nonmyristoylated forms of SIV/17E-Fr Nef
(Fig. 2) because most of the previously described func-
tions of Nef are dependent on the membrane-associated,
myristoylated form of Nef (i.e., CD4 down-regulation, en-
hanced viral infectivity, virion incorporation, and associ-
ation with the PAK-related kinase; Chowers et al., 1994;
Flaherty, Barber, and Clements, 1997; Harris and Neil,
1994; Pandori et al., 1996; Sawai et al., 1995; Bukovsky et
al., 1997). This characteristic may prove helpful in deter-
mining the identity of the kinase and may focus future
attention on examining the effect(s) of nonmyristoylated
forms of Nef present in the cytosol and nucleus
(Franchini et al., 1986; Kaminchik et al., 1991; Kienzle et
al., 1992; Ranki et al., 1994; Yu and Felsted, 1992).
Previous studies have shown that SIVmac239 Nef
(present in clone SIV/Fr-2) associates with pp62, pp97,
and pp35 in in vitro kinase assays (Baur et al., 1997;
Nunn and Marsh, 1996; Sawai et al., 1994). Our results
both confirm and extend these observations to include
SIV-infected rhesus macaque macrophages. It is thought
that pp62 is a PAK-related kinase (Nunn and Marsh,
1996; Sawai et al., 1996), that pp97 represents a PAK-
kinase substrate that coprecipitates with the Nef/kinase
complex (Nunn and Marsh, 1996), and that pp35 is Nef
phosphorylated by an unidentified serine kinase of NAKC
(Baur et al., 1997), henceforth referred to as SK-NAKC. Of
note, SIV/17E-Fr Nef did not associate with the activated
PAK-related kinase, nor did we observe any active src-
related kinases in association with either Nef protein;
src-related kinases autophosphorylate and thus result in
tyrosine phosphoproteins in the 55- to 62-kDa range
(Eiseman and Bolen, 1990). Our data also corroborate the
findings of Baur et al. (1997) and demonstrate for the first
time in the context of natural infection that in vitro
SIVmac239 Nef (present in SIV/Fr-2) is phosphorylated
by at least one of the Nef-associated kinase(s) (Fig. 4).
Two experimental results appear to distinguish the
SK-NAKC activity associated with SIV/Fr-2 Nef from the
kinase activity associated with SIV/17E-Fr Nef. First, SIV/
17E-Fr (2myr) Nef, but not SIV/Fr-2 (2myr) Nef, exhibited
enhanced kinase association/activity (Fig. 2). Second,
the kinase activity associated with SIV/17E-Fr Nef, but
not SK-NAKC, was detectable in GTP-based in vitro ki-
nase assays (Fig. 3). We have also confirmed that en-
hanced kinase activity occurs with SIV/17E-Fr (2myr) Nef
in the GTP-based assays (not shown). These findings do
not, however, rule out the possibility that SIV/17E-Fr Nef
associates with both the novel kinase and SK-NAKC. We
are currently designing experiments to address this pos-
sibility.
Although we have identified pp35 as phosphorylated
Nef, the identity of the kinase remains to be determined.
We are presently considering the following possibilities:
(1) both SIVmac239 Nef and SIV/17E-Fr Nef autophos-
FIG. 5. SDS–PAGE separation of Nef immunoprecipitates prepared
from [32P]orthophosphate-labeled CEM3174 cells transfected with SIV/
17E-Fr DNA or SIV/Fr-2 DNA, as described in Materials and Methods.
RTs (in cpm/ml) at the time of labeling were 154446 for SIV/17E-Fr and
186956 for SIV/Fr-2. Results are representative of at least two similar
independent experiments. The computer-generated images of the
scanned autoradiographs were produced using Adobe Photoshop 4.0
and Adobe Illustrator 6.0
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phorylate, but to different extents; (2) SIV/17E-Fr Nef
associates with a kinase that does not autophosphory-
late and is in such low abundance that it remains unde-
tectable in 35S-based IP analyses; and (3) both Nefs
associate with a kinase of low abundance that does not
autophosphorylate, but only SIV/17E-Fr Nef can serve as
a substrate for that kinase. Indeed, among the amino
acid differences between SIV/Fr-2 Nef and SIV/17E-Fr
Nef (P12-S, E75-K, E93-Q, M119-I, and E150-K, respec-
tively, for Fr-2 - 17E-Fr) is the presence of a serine in
SIV/17E-Fr Nef that does not exist in SIV/Fr-2 Nef. AT-
Pase and GTPase functions have been described for SIV
and HIV Nef (Guy et al., 1987; Nebrada et al., 1991);
however, the ability of Nef to autophosphorylate has
been controversial in the literature (Kaminchik et al.,
1990; Sawai et al., 1994) and not actively pursued in the
field. Thus, one of the two latter possibilities is more
likely. Two previously reported Nef-associated serine/
threonine kinases are MAPK (Greenway et al., 1996) and
PKCu (Smith et al., 1996). It is doubtful that MAPK is the
SIV/17E-Fr Nef-associated kinase because MAPK activ-
ity is inhibited by HIV Nef (Greenway et al., 1996) and
MAPK phosphorylates myelin basic protein (mbp),
whereas the novel kinase does not (data not shown). We
are currently examining PKCu, which is expressed in
hematopoetic cells, although primarily lymphocytes
(Smith et al., 1996), but of yet have no evidence to impli-
cate the involvement of this kinase.
In conclusion, our study characterized a novel kinase
activity associated with the Nef protein of the macro-
phage-tropic, neurovirulent clone, SIV/17E-Fr. The exis-
tence of at least two identified active Nef-associated
serine/threonine kinases (PAK, PKCu) suggests that the
ability of Nef to associate with kinases may be intrinsi-
cally important for its complete function. Uniquely, the
novel kinase preferentially associates with nonmyristoy-
lated Nef, suggesting a novel function for this Nef form,
perhaps in keeping with its different subcellular distribu-
tion. The identification of this kinase should help to
define this function of Nef. In addition, the distinct Nef-
associated kinase assay patterns described above for
SIV/Fr-2 and SIV/17E-Fr indicate that at least one of the
five amino acid differences between these two Nef pro-
teins is crucial for detectable association with activated
PAK, SK-NAKC, and/or the novel kinase. The relevant
amino acids (described above) are distinct from the R-R
and PXXP motifs previously demonstrated to be impor-
tant for Nef/PAK interactions (Lang et al., 1997; Sawai et
al., 1995) but may overlap the N-terminal region required
for Nef/SK-NAKC interaction (Baur et al., 1997). Further,
because SIV/17E-Fr nef is derived from SIV/17E-Br, a
neurovirulent virus obtained by in vivo passage of SIV-
mac239, our results suggest that although there may be
selective pressure toward Nef proteins that associate
with active PAK in cells isolated from the peripheral
blood of SIV-infected macaques (Sawai et al., 1996),
there is no absolute pressure to maintain this associa-
tion during infection of the central nervous system (CNS).
This conclusion questions the requirement of PAK-asso-
ciated Nefs for all SIV-induced pathology and thus sup-
ports the recent findings of Lang et al. (1997), which
demonstrate that macaques inoculated with SIV, harbor-
ing PXXP mutations in Nef that abrogate Nef/PAK asso-
ciation, develop AIDS despite a low frequency of nef
revertants.
Intriguingly, we have shown that Nef-associated ki-
nase activity is also packaged into SIV/17E-Fr virions
despite the absence of Nef-associated PAK and SK-
NAKC in SIV/Fr-2 virions, supporting further a unique role
for this SIV/17E-Fr Nef (Flaherty et al., 1997). In the same
study, we also determined that the infectivity of SIV/
17E-Fr virions is only slightly less than SIV/Fr-2 virions
(12% vs 17%, respectively, compared with 2% and 4% for
the nonmyristoylated Nefs, respectively, and 2% for SIV/
17E-FrDnef), suggesting that the novel kinase may also
modulate viral infectivity. We are currently addressing
this possibility and evaluating the replicative ability of
SIV/17E-Fr mutants unable to associate with this kinase.
To assess the relevance of this kinase to CNS disease,
it is of considerable interest to examine Nef-associated
kinase activity in other neurotropic, as well as non-
neurotropic, strains of SIV, and in infected cells of the
CNS, primarily brain macrophages or microglia
(Gabuzda et al., 1986; Gartner et al., 1986; Price et al.,
1988), astrocytes (He et al., 1997; Ranki et al., 1995; Saito
et al., 1994; Takahashi et al., 1996; Tornatore et al., 1994),
and endothelial cells (Mankowski et al., 1994; Moses et
al., 1993). Such results may help to define the critical
virus–cell interactions required to support productive in-
fection in the CNS leading to SIV- or HIV-induced neuro-
logical disease.
MATERIALS AND METHODS
Cell culture and metabolic labeling
Macrophages derived from rhesus macaque PBMCs
were prepared as described previously (Flaherty et al.,
1997). CEM3174 cells were grown in RPMI media (Par-
agon Biotech Inc., Baltimore, MD) supplemented with
10% fetal bovine serum (Atlanta Biologicals, Norcross,
GA), 50 mg/ml gentamicin (Life Technologies, Gaithers-
burg, MD), 2 mM pyruvate (Sigma, St. Louis, MO), and 2
mM glutamine (Life Technologies). For 35S-labeling,
CEM3174 cells were incubated in methionine-free RPMI
(Life Technologies) containing 2% fetal bovine serum, 2
mM pyruvate, and 2 mM glutamine for 1 h and then
supplemented for 16 h with Trans35S-Label (ICN phar-
maceuticals, Irvine, CA). For 32P-labeling, CEM3174 cells
were incubated in phosphate-free RPMI (Life Technolo-
gies) containing 10% dialyzed fetal bovine serum (Life
Technologies) for 1 h and then supplemented for 16 h
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with 32P-orthophosphate (NEN Life Science Products,
Boston, MA).
Infection of rhesus macaque macrophages
Monolayers of rhesus macaque macrophages were
incubated in six-well plates with 100,000 cpm of reverse
transcriptase (RT) activity of the SIV molecular clones for
8–16 h, after which the inoculum was removed and the
macrophages were washed twice with media. Virus
growth was monitored by analyzing supernatants for RT
activity as described previously (Clabough et al., 1991).
Transfection of SIV recombinant clones
The construction of the molecular clones SIV/17E-Fr,
SIV/Fr-2, SIV/17E-Fr(2myr), SIV/Fr-2(2myr), and SIV 17E-
Fr(Dnef) have been described previously (Flaherty et al.,
1997). CEM3174 or U937 cells were transfected with 12
mg of infectious DNA by electroporation, and the cell-free
supernatants from the transfected CEM3174 cells were
aliquoted and stored at 280°C for virus stocks.
Immunoprecipitation, Western blotting, and in vitro
kinase assays
Transfected cells were pelleted by low-speed centrif-
ugation, washed in ice-cold PBS containing 200 mM
sodium orthovanadate (SOV, Aldrich Chemical, Milwau-
kee, WI), and lysed in ice-cold lysis buffer containing 50
mM Tris–HCl (pH 8.0), 0.5% Nonidet P-40 (ICN Biomedi-
cals, Aurora, OH), 2 mM EDTA, 137 mM NaCl, 10% glyc-
erol, 2 mg/ml aprotinin (Sigma), 100 mM leupeptin (Sig-
ma), and 2 mM SOV. Whole-cell lysates were prepared
from infected rhesus macaque macrophages in the
same manner, except that the adherent macrophages
were scraped into ice-cold PBS containing 200 mM SOV
before low-speed centrifugation. Insoluble material was
pelleted by high-speed centrifugation (;10,000g), and
protein content was determined using the BioRad protein
assay system (BioRad Laboratories, Hercules, CA).
Equal amounts of lysate proteins were precleared by
incubation with normal rabbit serum for 1 h at 4°C
followed by incubation with Protein A–Sepharose 4 Fast
Flow (Pharmacia, Piscataway, NY) for 1 h at 4°C. Poly-
clonal antiserum against SIVmac239 Nef was prepared
in rabbits immunized with purified Nef protein (a gift from
Casey Morrow, University of Alabama at Birmingham).
The pre-cleared lysates were incubated first with poly-
clonal Nef antiserum overnight at 4°C and then with
Protein A–Sepharose for 1 h at 4°C. Immunoprecipitates
(IPs) prepared from radiolabeled cells or IPs to be used
in Western blot analyses were washed four times with
lysis buffer, solubilized in SDS–PAGE loading buffer
(Laemmli, 1970), and heated at .90°C for 5 min before
electrophoretic separation. Separated proteins were
transfered to Immobilon (Millipore Corporation, Bedford,
MA) using the BioRad semidry transfer apparatus (Bio-
Rad Laboratories) and incubated with anti-Nef antiserum
followed by goat anti-rabbit horseradish peroxidase
(HRP)-conjugated Ig (DAKO, Carpinteria, CA). Detection
of immune complexes was achieved using enhanced
chemiluminescence (Amersham, Arlington Heights, IL).
The IPs to be used for in vitro kinase assays were
washed three times with lysis buffer and once with
kinase buffer (50 mM Tris–HCl, pH 8.0, 10 mM NaCl, 1%
Triton X-100, 5 mM MgCl2, 5 mM MnCl2, with or without
10 mM staurosporine; Calbiochem, La Jolla, CA), 100 mM
genistein (Life Technologies), or 1% DMSO, and resus-
pended for 15 min in kinase buffer containing 2 mM SOV
and 200 mM [g-32P]ATP (3000 mCi/mmol, NEN Research
Products). Immune complexes were washed with ice-
cold lysis buffer and separated by 9–12% SDS–PAGE.
Gels were fixed in 10% acetic acid–30% methanol for
15–30 min, dried, and exposed to film (NEN Life Science
Products).
Phosphoamino acid analysis
After autoradiography, pp35 was excised from the re-
hydrated kinase gel, digested with trypsin (Worthington,
Freehold, NJ) overnight, and subjected to acid hydrolysis
for 1 h at 110°C as described previously (Van Der Geer et
al., 1991). Samples were lyophilized and resuspended in
electrophoresis buffer before separation (along with
phosphoamino acid standards) on cellulose TLC plates
(EM Science, Gibbstown, NJ) as described previously
(Jelinek and Weber, 1993; Van Der Geer et al., 1991).
Phosphoamino acid standards were localized with nin-
hydrin spray, and the phosphorylated amino acid(s) from
pp35 were detected by autoradiography.
Two-dimensional electrophoresis
IPs were processed as described above for in vitro
kinase analysis or prepared from 35S-labeled transfected
CEM3174 cells. Proteins present in the IPs were sepa-
rated in the first dimension by SDS–PAGE (10% polyacryl-
amide gel). Gels containing the Nef kinase samples were
processed as described above, and the gels containing
the 35S-labeled Nef IPs were fixed in 20% isopropanol–
10% acetic acid for 1 h, washed 3–4 times in deionized
water, and emersed in 1 M sodium salicylate for 30 min
before drying. After autoradiography, the bands corre-
sponding to 35S-labeled p35 or 32P-labeled p35 were
excised from the dried gels and washed in 20% ethanol
for 10 min, 23 isoelectric focusing (IEF) solublization
buffer (Novex, San Diego, CA) containing 20% ethanol for
10 min, and IEF cathode buffer (Novex) for 10 min. The
gel slices were then loaded vertically into the lanes of
IEF gels (Novex) along with IEF standards (BioRad), and
the proteins were separated according to the manufac-
turer’s specifications. Note that separation of bands that
appear to be horizontal in the first dimension will appear
as spots when loaded vertically and separated in the
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second dimension. After separation, the IEF gels con-
taining 32P-labeled p35 were processed as described
above for the kinase assay gels, and the IEF gels con-
taining the 35S-labeled p35 were emersed in 1M sodium
salicylate for 30 min before drying and autoradiography.
After autoradiography, the IEF gels to be used in Western
anaylses were rehydrated for 30 min in SDS–PAGE run-
ning buffer (0.25 M Tris, 1.9 M glycine, 0.35 M SDS) and
then soaked for 15 min in transfer buffer (0.025 M Tris,
0.19 M glycine, 20% methanol) before transfer and prob-
ing with Nef antiserum as described above.
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